On the public citation graph
Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer
0 signed · 175 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.283.15.2008openalex-snapshot
Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting
inferredcites →https://doi.org/10.1002/bjs.10664openalex-snapshot
Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer
inferredcites →https://doi.org/10.1002/bjs.10984openalex-snapshot
Randomized clinical trial of short or long interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer
inferredcites →https://doi.org/10.1002/bjs.4162openalex-snapshot
Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer
inferredcites →https://doi.org/10.1002/bjs.5506openalex-snapshot
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
inferredcites →https://doi.org/10.1002/bjs.6377openalex-snapshot
Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis
inferredcites →https://doi.org/10.1002/bjs.6914openalex-snapshot
Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer
inferredcites →https://doi.org/10.1002/bjs.8702openalex-snapshot
Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer
inferredcites →https://doi.org/10.1002/bjs.8732openalex-snapshot
Critical appraisal of the ‘wait and see’ approach in rectal cancer for clinical complete responders after chemoradiation
inferredcites →https://doi.org/10.1002/bjs.9112openalex-snapshot
Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer
inferredcites →https://doi.org/10.1002/bjs.9811openalex-snapshot
Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer
inferredcites →https://doi.org/10.1002/cncr.11075openalex-snapshot
Response to preoperative chemoradiation increases the use of sphincter‐preserving surgery in patients with locally advanced low rectal carcinoma
inferredcites →https://doi.org/10.1002/ijc.30562openalex-snapshot
The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation
inferredcites →https://doi.org/10.1002/jso.20815openalex-snapshot
Effect of time interval between surgery and preoperative chemoradiotherapy with 5‐fluorouracil or 5‐fluorouracil and oxaliplatin on outcomes in rectal cancer
inferredcites →https://doi.org/10.1002/jso.23394openalex-snapshot
Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5‐fluorouracil for locally advanced rectal cancer
inferredcites →https://doi.org/10.1002/jso.23665openalex-snapshot
Impact of interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer on surgical and oncologic outcome
inferredcites →https://doi.org/10.1007/s00268-008-9520-1openalex-snapshot
Sphincter‐Preserving Operations Following Preoperative Chemoradiation: An Alternative to Abdominoperineal Resection for Lower Rectal Cancer?
inferredcites →https://doi.org/10.1007/s00432-014-1843-8openalex-snapshot
Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response
inferredcites →https://doi.org/10.1007/s10151-016-1514-7openalex-snapshot
Surgical timing after chemoradiotherapy for rectal cancer, analysis of technique (STARRCAT): results of a feasibility multi-centre randomized controlled trial
inferredcites →https://doi.org/10.1007/s10350-003-0062-1openalex-snapshot
Rate of Pathologic Complete Response With Increased Interval Between Preoperative Combined Modality Therapy and Rectal Cancer Resection
inferredcites →https://doi.org/10.1007/s10350-004-6579-0openalex-snapshot
Longer Time Interval Between Completion of Neoadjuvant Chemoradiation and Surgical Resection Does Not Improve Downstaging of Rectal Carcinoma
inferredcites →https://doi.org/10.1007/s11605-010-1197-8openalex-snapshot
Neoadjuvant Therapy for Rectal Cancer: The Impact of Longer Interval Between Chemoradiation and Surgery
inferredcites →https://doi.org/10.1016/0197-2456(95)00134-4openalex-snapshot
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
inferredcites →https://doi.org/10.1016/j.amjsurg.2006.08.061openalex-snapshot
Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer
inferredcites →https://doi.org/10.1016/j.ejca.2012.09.026openalex-snapshot
Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: A meta analysis
inferredcites →https://doi.org/10.1016/j.ijrobp.2007.11.035openalex-snapshot
Interval Between Surgery and Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Does Delayed Surgery Have an Impact on Outcome?
inferredcites →https://doi.org/10.1016/j.ijrobp.2015.10.061openalex-snapshot
Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial
inferredcites →https://doi.org/10.1016/j.jamcollsurg.2015.04.010openalex-snapshot
Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation
inferredcites →https://doi.org/10.1016/j.radonc.2016.03.017openalex-snapshot
Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer
inferredcites →https://doi.org/10.1016/s0140-6736(18)31078-xopenalex-snapshot
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
inferredcites →https://doi.org/10.1016/s0167-8140(84)80003-1openalex-snapshot
Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable colorectal cancer
inferredcites →https://doi.org/10.1016/s0960-7404(99)00017-1openalex-snapshot
Neoadjuvant therapy in the treatment of high risk rectal carcinoma
inferredcites →https://doi.org/10.1016/s1470-2045(10)70172-8openalex-snapshot
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
inferredcites →https://doi.org/10.1016/s1470-2045(12)70187-0openalex-snapshot
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
inferredcites →https://doi.org/10.1016/s1470-2045(15)00054-6openalex-snapshot
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
inferredcites →https://doi.org/10.1016/s1470-2045(17)30086-4openalex-snapshot
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
inferredcites →https://doi.org/10.1056/nejmoa040694openalex-snapshot
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
inferredcites →https://doi.org/10.1093/annonc/mdw370.16openalex-snapshot
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: final analyses
inferredcites →https://doi.org/10.1097/01.sla.0000133083.54934.aeopenalex-snapshot
Classification of Surgical Complications
inferredcites →https://doi.org/10.1097/dcr.0b013e3182281f4bopenalex-snapshot
Timing of Surgery Following Preoperative Therapy in Rectal Cancer: The Need for a Prospective Randomized Trial?
inferredcites →https://doi.org/10.1097/sla.0000000000000368openalex-snapshot
Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer
inferredcites →https://doi.org/10.1097/sla.0000000000002523openalex-snapshot
Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer
inferredcites →https://doi.org/10.1097/sla.0b013e31817fc2a0openalex-snapshot
Optimal Surgery Time After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancers
inferredcites →https://doi.org/10.1097/sla.0b013e3181b91e63openalex-snapshot
Predictive Factors of Pathologic Complete Response After Neoadjuvant Chemoradiation for Rectal Cancer
inferredcites →https://doi.org/10.1097/sla.0b013e3182196e1fopenalex-snapshot
Optimal Timing of Surgery After Chemoradiation for Advanced Rectal Cancer
inferredcites →https://doi.org/10.1097/sla.0b013e31825b3a2bopenalex-snapshot
Pulmonary Recurrence Predominates After Combined Modality Therapy for Rectal Cancer
inferredcites →https://doi.org/10.1111/j.1463-1318.2011.02815.xopenalex-snapshot
Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short‐course radiotherapy or long‐term chemoradiotherapy, both with delayed surgery
inferredcites →https://doi.org/10.1136/bmj.b2535openalex-snapshot
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
inferredcites →https://doi.org/10.1155/2016/7870815openalex-snapshot
Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?
inferredcites →https://doi.org/10.1186/1471-2288-5-13openalex-snapshot
Estimating the mean and variance from the median, range, and the size of a sample
inferredcites →https://doi.org/10.1186/s12874-016-0136-0openalex-snapshot
Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review
inferredcites →https://doi.org/10.1200/jco.2009.25.8376openalex-snapshot
Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
inferredcites →https://doi.org/10.1200/jco.2010.34.4911openalex-snapshot
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
inferredcites →https://doi.org/10.1200/jco.2011.39.6036openalex-snapshot
Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)
inferredcites →https://doi.org/10.1200/jco.2011.39.7901openalex-snapshot
Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer
inferredcites →https://doi.org/10.1200/jco.2011.40.1836openalex-snapshot
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
inferredcites →https://doi.org/10.1200/jco.2012.42.9597openalex-snapshot
Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
inferredcites →https://doi.org/10.1200/jco.2014.32.15_suppl.3603openalex-snapshot
Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in patients with stage II and III rectal cancer.
inferredcites →https://doi.org/10.1200/jco.2016.66.6198openalex-snapshot
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
inferredcites →https://doi.org/10.1200/jco.2016.67.6049openalex-snapshot
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
inferredcites →https://doi.org/10.1245/s10434-008-9892-3openalex-snapshot
An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer
inferredcites →https://doi.org/10.1245/s10434-011-2209-yopenalex-snapshot
Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis
inferredcites →https://doi.org/10.1245/s10434-012-2327-1openalex-snapshot
Impact of Interval between Neoadjuvant Chemoradiotherapy and TME for Locally Advanced Rectal Cancer on Pathologic Response and Oncologic Outcome
inferredcites →https://doi.org/10.1245/s10434-016-5294-0openalex-snapshot
Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study
inferredcites →https://doi.org/10.14456/apjcp.2016.269openalex-snapshot
Appropriate Timing of Surgery after Neoadjuvant Chemo- Radiation Therapy for Locally Advanced Rectal Cancer
inferredcites →https://doi.org/10.1590/s0102-67202013000100007openalex-snapshot
Existem benefícios com a cirurgia retardada após radioterapia e quimioterapia neoadjuvante no câncer de reto localmente avançado?
inferredcites →https://doi.org/10.18632/oncotarget.9995openalex-snapshot
Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis
inferredcites →https://doi.org/10.3310/hta7270openalex-snapshot
Evaluating non-randomised intervention studies
inferredcites →https://doi.org/10.3389/fonc.2015.00286openalex-snapshot
Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer
inferredcites →https://doi.org/10.3393/ac.2018.01.01openalex-snapshot
Optimal Time Interval for Surgery After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: Analysis of Health Insurance Review and Assessment Service Data
inferredcites →https://doi.org/10.3978/j.issn.2078-6891.2013.025openalex-snapshot
Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study.
inferredcites →https://doi.org/10.4103/0971-5851.144986openalex-snapshot
Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter?
inferredcites →https://doi.org/10.4143/crt.2017.252openalex-snapshot
The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma
inferredcites →https://doi.org/10.4174/jkss.2013.84.6.338openalex-snapshot
Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
inferredcites →https://doi.org/10.4251/wjgo.v8.i9.695openalex-snapshot
Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer
inferredcites →https://doi.org/10.7314/apjcp.2016.17.1.89openalex-snapshot
Impact of Time Interval Between Chemoradiation and Surgery on Pathological Complete Response and Survival in Rectal Cancer
inferredcites →https://doi.org/10.7326/0003-4819-151-4-200908180-00135openalex-snapshot
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4596447openalex-extracted
Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients - A Prospective Randomized Controlled Phase III Study
inferred← citeshttps://doi.org/10.1001/jamasurg.2021.4566openalex-snapshot
Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation
inferred← citeshttps://doi.org/10.1001/jamasurg.2023.2521openalex-snapshot
Time Interval Between the End of Neoadjuvant Therapy and Elective Resection of Locally Advanced Rectal Cancer in the CRONOS Study
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm144openalex-snapshot
Carcinoma of the Colon and Rectum
inferred← citeshttps://doi.org/10.1002/9781119518495.ch4openalex-snapshot
Neoadjuvant Therapy Options for Advanced Rectal Cancer
inferred← citeshttps://doi.org/10.1002/bjs.11324openalex-snapshot
Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer
inferred← citeshttps://doi.org/10.1002/bjs.11416openalex-snapshot
Author response to: Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer
inferred← citeshttps://doi.org/10.1002/bjs.11417openalex-snapshot
Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer
inferred← citeshttps://doi.org/10.1002/bjs.11574openalex-snapshot
Author response to: Should a minimum 8-week interval between preoperative radiotherapy and surgery become the standard of care? No, it shouldn't
inferred← citeshttps://doi.org/10.1002/bjs.11575openalex-snapshot
Should a minimum 8-week interval between preoperative radiotherapy and surgery become the standard of care? No, it shouldn't
inferred← citeshttps://doi.org/10.1002/bjs.12014openalex-snapshot
Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit
inferred← citeshttps://doi.org/10.1002/jso.27105openalex-snapshot
Standard versus longer interval of radical resection after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A 20‐year single‐center experience & propensity‐score matching
inferred← citeshttps://doi.org/10.1002/jso.27273openalex-snapshot
Determining the optimal radiation‐surgery interval (RSI) for oncologic proctectomy following radiotherapy for rectal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/jso.70263openalex-snapshot
Pelvic MRI Following Total Neoadjuvant Therapy for Rectal Cancer Poorly Predicts a Complete Clinical Response
inferred← citeshttps://doi.org/10.1002/mco2.70222openalex-snapshot
Short‐Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients
inferred← citeshttps://doi.org/10.1007/s00384-020-03829-yopenalex-snapshot
Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China
inferred← citeshttps://doi.org/10.1007/s00384-022-04103-zopenalex-snapshot
A multicentre cohort study assessing the utility of routine blood tests as adjuncts to identify complete responders in rectal cancer following neoadjuvant chemoradiotherapy
inferred← citeshttps://doi.org/10.1007/s00384-022-04122-wopenalex-snapshot
Does a long interval between neoadjuvant chemoradiotherapy and surgery benefit the clinical outcomes of locally advanced rectal cancer? A systematic review and meta analyses
inferred← citeshttps://doi.org/10.1007/s00384-023-04558-8openalex-snapshot
Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials
inferred← citeshttps://doi.org/10.1007/s11605-020-04665-9openalex-snapshot
Development and Validation of a Clinical Risk Score for Intensive Care Resource Utilization After Colon Cancer Surgery: a Practical Guide to the Selection of Patients During COVID-19
inferred← citeshttps://doi.org/10.1007/s13304-020-00747-0openalex-snapshot
Delaying surgery by more than 10 weeks after long-course neoadjuvant radiotherapy in locally advanced rectal cancer patients improves pathologic complete response
inferred← citeshttps://doi.org/10.1007/s13304-021-01189-yopenalex-snapshot
Effect of delaying surgery by more than 10 weeks after neoadjuvant therapy in rectal cancer: a single institution experience
inferred← citeshttps://doi.org/10.1016/b978-0-323-90055-3.00058-2openalex-snapshot
Neoadjuvant, adjuvant, and intraoperative radiotherapy for rectal cancer
inferred← citeshttps://doi.org/10.1016/j.amjsurg.2020.01.013openalex-snapshot
Reoperative laparoscopic rectal surgery: Another potential tool for the expert’s toolbox
inferred← citeshttps://doi.org/10.1016/j.asjsur.2025.12.231openalex-snapshot
Impact of prolonged interval between neoadjuvant chemoradiotherapy and surgery on outcomes in locally advanced rectal cancer: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.clcc.2020.07.009openalex-snapshot
A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy
inferred← citeshttps://doi.org/10.1016/j.clcc.2020.12.005openalex-snapshot
Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Recent Advances and Ongoing Challenges
inferred← citeshttps://doi.org/10.1016/j.clon.2020.06.008openalex-snapshot
Neoadjuvant Radiotherapy Dose Escalation in Locally Advanced Rectal Cancer: a Systematic Review and Meta-analysis of Modern Treatment Approaches and Outcomes
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2023.103991openalex-snapshot
Predictive biomarkers in radioresistant rectal cancer: A systematic review
inferred← citeshttps://doi.org/10.1016/j.ejca.2024.114044openalex-snapshot
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
inferred← citeshttps://doi.org/10.1016/j.ejso.2019.10.010openalex-snapshot
Global variation in the long-term outcomes of ypT0 rectal cancers
inferred← citeshttps://doi.org/10.1016/j.ejso.2020.07.024openalex-snapshot
Reply to: The impact of circumferential tumor location on the clinical outcomes of rectal cancers receiving neoadjuvant chemoradiation and surgery-does is really matter?
inferred← citeshttps://doi.org/10.1016/j.ejso.2021.01.025openalex-snapshot
Optimal timing of surgery following breast cancer neoadjuvant chemotherapy: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ejso.2022.02.012openalex-snapshot
Initial magnetic resonance imaging tumour regression grade (mrTRG) as response evaluation after neoadjuvant treatment predicts sustained complete response in patients with rectal cancer
inferred← citeshttps://doi.org/10.1016/j.jcol.2019.10.013openalex-snapshot
Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.radonc.2020.09.026openalex-snapshot
Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials
inferred← citeshttps://doi.org/10.1016/j.rx.2024.06.009openalex-snapshot
Papel de la resonancia magnética en la evaluación del cáncer de recto tras terapia neoadyuvante
inferred← citeshttps://doi.org/10.1016/j.rxeng.2025.101625openalex-snapshot
Role of magnetic resonance imaging in the evaluation of rectal cancer after neoadjuvant therapy
inferred← citeshttps://doi.org/10.1016/j.surge.2022.06.001openalex-snapshot
Impact of frailty on oncological outcomes in patients undergoing surgery for colorectal cancer – A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.surge.2024.03.001openalex-snapshot
Prolonged interval to surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1038/s41598-020-69345-9openalex-snapshot
Machine learning for predicting pathological complete response in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
inferred← citeshttps://doi.org/10.1038/s41598-025-10768-7openalex-snapshot
Metformin’s impact on tumor regression grade in diabetic patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
inferred← citeshttps://doi.org/10.1080/07357907.2025.2595536openalex-snapshot
Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study
inferred← citeshttps://doi.org/10.1093/bjs/znab011openalex-snapshot
Impact of COVID-19 on treatment modalities and short-term outcomes of rectal cancer following neoadjuvant chemoradiotherapy: a retrospective study
inferred← citeshttps://doi.org/10.1093/bjs/znab194openalex-snapshot
Prevalence of nodal involvement in rectal cancer after chemoradiotherapy
inferred← citeshttps://doi.org/10.1093/bjs/znac140openalex-snapshot
Organ preservation in rectal cancer: review of contemporary management
inferred← citeshttps://doi.org/10.1093/bjs/znac317openalex-snapshot
Minimum standards of pelvic exenterative practice: PelvEx Collaborative guideline
inferred← citeshttps://doi.org/10.1093/bjs/znad113openalex-snapshot
Timing of rectal cancer surgery after short-course radiotherapy: national database study
inferred← citeshttps://doi.org/10.1093/bjs/znad120openalex-snapshot
Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis
inferred← citeshttps://doi.org/10.1093/bjs/znad177openalex-snapshot
Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials
inferred← citeshttps://doi.org/10.1097/coc.0000000000000846openalex-snapshot
Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
inferred← citeshttps://doi.org/10.1097/dcr.0000000000001927openalex-snapshot
A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer
inferred← citeshttps://doi.org/10.1097/dcr.0000000000002450openalex-snapshot
Limits of Clinical Restaging in Detecting Responders After Neoadjuvant Therapies for Rectal Cancer
inferred← citeshttps://doi.org/10.1097/dcr.0000000000002509openalex-snapshot
Is It Really the Short-Course Radiation?
inferred← citeshttps://doi.org/10.1097/dcr.0000000000003057openalex-snapshot
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer 2023 Supplement
inferred← citeshttps://doi.org/10.1097/dcr.0000000000003477openalex-snapshot
Final Results of the GRECCAR-6 Trial on Waiting Period Following Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: 5 Years of Follow-up
inferred← citeshttps://doi.org/10.1111/codi.16315openalex-snapshot
Patient‐ and physician‐reported radiation‐induced toxicity of short‐course radiotherapy with a prolonged interval to surgery for rectal cancer
inferred← citeshttps://doi.org/10.1111/codi.70188openalex-snapshot
Risk factors and risk prediction modelling for pelvic sepsis and anastomotic leak following robotic total mesorectal excision with primary anastomosis for rectal cancer
inferred← citeshttps://doi.org/10.1111/his.15192openalex-snapshot
Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant‐treated rectal adenocarcinoma
inferred← citeshttps://doi.org/10.1155/2022/8197701openalex-snapshot
Effects of Neoadjuvant Radiotherapy on Postoperative Complications in Rectal Cancer: A Meta-Analysis
inferred← citeshttps://doi.org/10.1177/10849785251389350openalex-snapshot
The Impact of Gastric Anatomical Subdivisions on the Response to Neoadjuvant Chemotherapy in Gastric Cancer
inferred← citeshttps://doi.org/10.1186/s12885-026-15786-wopenalex-snapshot
Significance of nodal yield after rectal resection in the TNT era: does count matter?
inferred← citeshttps://doi.org/10.1186/s12957-023-03087-6openalex-snapshot
Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s12957-023-03251-yopenalex-snapshot
Optimal timing of surgery for gastric cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1200/jco.19.01722openalex-snapshot
Upfront Chemotherapy Followed by Chemoradiation Remains the Sequence of Choice for Total Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer
inferred← citeshttps://doi.org/10.1245/s10434-020-08615-2openalex-snapshot
Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1245/s10434-024-15669-zopenalex-snapshot
Editorial: “Pathologic Complete Response, Total Neoadjuvant Therapy, and the Survival Paradox in Locally Advanced Rectal Cancer,” by Goffredo et al. Without Constancy There is Neither Love, Friendship, Nor Virtue in the World
inferred← citeshttps://doi.org/10.12998/wjcc.v9.i30.9077openalex-snapshot
Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature
inferred← citeshttps://doi.org/10.18502/acta.v59i5.6658openalex-snapshot
An Expert Opinion Regarding the Management of Lower Gastrointestinal Cancers During COVID-19 Outbreak in Iran: A Brief Report
inferred← citeshttps://doi.org/10.21203/rs.3.rs-32347/v1openalex-snapshot
Impact of intratumor heterogeneity on diffusion-weighted MRI as a prognostic indicator in lower rectal cancer
inferred← citeshttps://doi.org/10.2147/cmar.s299364openalex-snapshot
Prognostic Impact of Pretreatment Elevated and Normalized Carcinoembryonic Antigen Levels After Neoadjuvant Chemoradiotherapy in Resected Locally Advanced Rectal Cancer Patients
inferred← citeshttps://doi.org/10.21873/invivo.12001openalex-snapshot
The Number of Harvested LNs Is an Independent Prognostic Factor in Lymph Node Metastasis-negative Patients Who Received Curative Esophagectomy
inferred← citeshttps://doi.org/10.21873/invivo.12012openalex-snapshot
The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery
inferred← citeshttps://doi.org/10.23736/s2724-5691.21.08770-0openalex-snapshot
Time interval between neoadjuvant radio-chemotherapy and surgery in rectal cancer: is the long interval correct for all patients?
inferred← citeshttps://doi.org/10.33540/171openalex-snapshot
Connecting the dots: a multidisciplinary approach to optimize rectal cancer treatment outcomes
inferred← citeshttps://doi.org/10.33612/diss.789782613openalex-snapshot
Optimizing the treatment of locally advanced and recurrent rectal cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1513716openalex-snapshot
Comparison of immunotherapy based total neoadjuvant therapy or standard neoadjuvant chemoradiation for locally advanced rectal cancer: a multi-institutional retrospective study
inferred← citeshttps://doi.org/10.3389/fonc.2020.01369openalex-snapshot
Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm
inferred← citeshttps://doi.org/10.3389/fonc.2024.1450994openalex-snapshot
A management of patients achieving clinical complete response after neoadjuvant therapy and perspectives: on locally advanced rectal cancer
inferred← citeshttps://doi.org/10.3389/fonc.2024.1477510openalex-snapshot
Nonoperative management of rectal cancer
inferred← citeshttps://doi.org/10.3390/cancers12123655openalex-snapshot
Impact of Total Neoadjuvant Therapy vs. Standard Chemoradiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials
inferred← citeshttps://doi.org/10.3390/cancers13236074openalex-snapshot
Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01)
inferred← citeshttps://doi.org/10.3390/cancers14225709openalex-snapshot
How We Treat Localized Rectal Cancer—An Institutional Paradigm for Total Neoadjuvant Therapy
inferred← citeshttps://doi.org/10.3390/cancers17152540openalex-snapshot
Neoadjuvant Treatment for Locally Advanced Rectal Cancer: Current Status and Future Directions
inferred← citeshttps://doi.org/10.3390/cancers18132117openalex-snapshot
Clinical Impact of Total Neoadjuvant Therapy Combined with Dose-Escalated Intensity-Modulated Radiotherapy for Lower Rectal Cancer: A Comparison with Conventional Neoadjuvant Chemoradiotherapy
inferred← citeshttps://doi.org/10.3393/ac.2023.00899.0128openalex-snapshot
The impact of short-course total neoadjuvant therapy, long-course chemoradiotherapy, and upfront surgery on the technical difficulty of total mesorectal excision: an observational study with an intraoperative perspective
inferred← citeshttps://doi.org/10.36401/jipo-20-31openalex-snapshot
Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
inferred← citeshttps://doi.org/10.3857/roj.2024.00423openalex-snapshot
Could neoadjuvant radiation dose escalation increase tumor response and recurrence-free survival in patients with locally advanced rectal cancer?
inferred← citeshttps://doi.org/10.4103/jcrt.jcrt_1273_20openalex-snapshot
Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer
inferred← citeshttps://doi.org/10.4240/wjgs.v18.i5.115825openalex-snapshot
Mucinous rectal adenocarcinoma and neoadjuvant therapy: Implications for surgical practice
inferred← citeshttps://doi.org/10.4251/wjgo.v15.i5.700openalex-snapshot
Restaging rectal cancer following neoadjuvant chemoradiotherapy
inferred← citeshttps://doi.org/10.4999/uhod.214936openalex-snapshot
Neoadjuvant Radiotherapy in Rectal Cancer: A Single Center Experience
inferred← citeshttps://doi.org/10.6084/m9.figshare.23751847openalex-snapshot
Additional file 1 of Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23751850openalex-snapshot
Additional file 2 of Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23751853openalex-snapshot
Additional file 3 of Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.23751856openalex-snapshot
Additional file 4 of Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.61091/jpms202413216openalex-snapshot
Treatment Outcome in Locally Advanced Rectal Carcinoma and Its Correlation with Hypo-Fractionated Radiotherapy and Concurrent Chemoradiotherapy
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.